Increasing provider awareness of Lp(a) testing for patients at risk for cardiovascular disease: A comparative study
Background: Lipoprotein(a) [Lp(a)] is a low-density lipoprotein variant with atherogenic, thrombogenic, and pro-inflammatory properties that may have numerous pathologic effects, including dyslipidemia. Screening for Lp(a) is clinically significant, due to its causal role in atherosclerotic cardiova...
Saved in:
| Main Authors: | Wael E. Eid, Emma Hatfield Sapp, Callen Conroy, Coby Bessinger, Cassidy L. Moody, Ryan Yadav, Reece Tolliver, Joseph Nolan, Suzanne M. Francis |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-03-01
|
| Series: | American Journal of Preventive Cardiology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666667724002630 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gallic acid: a dietary metabolite’s therapeutic potential in the management of atherosclerotic cardiovascular disease
by: Xiao-Lan Zhao, et al.
Published: (2025-01-01) -
Concept of a human-centered electronic health record
by: Remlinger Wolfram, et al.
Published: (2024-12-01) -
Lipoprotein (a) Testing in Patients With Atherosclerotic Cardiovascular Disease in 5 Large US Health Systems
by: Nishant P. Shah, et al.
Published: (2024-11-01) -
Nurses’ Perceptions of Electronic Health Record Usability in Obstetrics and Gynecology
by: Zeynep OĞUL
Published: (2024-12-01) -
Context-Aware Electronic Health Record—Internet of Things and Blockchain Approach
by: Tiago Guimarães, et al.
Published: (2024-12-01)